» Articles » PMID: 14614994

Characteristics of a Two-stage Screen for Incident Dementia

Overview
Publisher Elsevier
Specialty Public Health
Date 2003 Nov 15
PMID 14614994
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: To avoid costly evaluation of healthy individuals, efficient methods of screening for incident dementia must combine adequate sensitivity and high specificity. Two-stage screening may offer improvements over single-stage methods. We therefore investigated a two-stage screening protocol for incident dementia among 3,308 elderly.

Methods: We administered the Modified Mini-Mental-State (3MS) or, rarely, Jorm's IQCODE, to a validation sample of 441 high-risk respondents. Informants then completed the Dementia Questionnaire (DQ). Finally, all 441 sample members underwent physical, neurologic, and neuropsychologic assessment. We studied the sensitivity and specificity of the 3MS/IQCODE and DQ using Receiver-Operating Characteristic analyses.

Results: A 3MS cut point of 82/83 (of 100) yielded sensitivity and specificity of 91.5 and 90.1%. With 3MS scores of < or =82, a DQ cut point of 2/3 (of five) yielded conditional sensitivity and specificity of 90.2 and 55.3%. Combining these instruments yielded sensitivity and specificity of 82.5 and 95.6%. Age stratification and use of longitudinal decline score criteria did not materially improve these figures.

Conclusions: The improved specificity of the two-stage approach offers economies that are attractive, particularly if sensitivity can be enhanced, for example, by examination of a high-risk validation sample.

Citing Articles

Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a general practice (primary care) setting.

K Burton J, Fearon P, Noel-Storr A, McShane R, Stott D, Quinn T Cochrane Database Syst Rev. 2021; 7:CD010771.

PMID: 34278564 PMC: 8406468. DOI: 10.1002/14651858.CD010771.pub3.


Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations.

Quinn T, Fearon P, Noel-Storr A, Young C, McShane R, Stott D Cochrane Database Syst Rev. 2021; 7:CD010079.

PMID: 34278562 PMC: 8407460. DOI: 10.1002/14651858.CD010079.pub3.


Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting.

K Burton J, Fearon P, Noel-Storr A, McShane R, Stott D, Quinn T Cochrane Database Syst Rev. 2021; 7:CD010772.

PMID: 34278561 PMC: 8406705. DOI: 10.1002/14651858.CD010772.pub3.


Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early detection of dementia across a variety of healthcare settings.

K Burton J, Stott D, McShane R, Noel-Storr A, Swann-Price R, Quinn T Cochrane Database Syst Rev. 2021; 7:CD011333.

PMID: 34275145 PMC: 8406787. DOI: 10.1002/14651858.CD011333.pub3.


Challenges in Measuring Applied Cognition: Measurement Properties and Equivalence of the Functional Assessment in Acute Care Multidimensional Computerized Adaptive Test (FAMCAT) Applied Cognition Item Bank.

Teresi J, Ocepek-Welikson K, Kleinman M, Cheville A, Ramirez M Arch Phys Med Rehabil. 2021; 103(5S):S118-S139.

PMID: 33556349 PMC: 8344387. DOI: 10.1016/j.apmr.2020.12.029.